Astera Labs (ALAB) Projected to Post Quarterly Earnings on Tuesday

Astera Labs (NASDAQ:ALAB) is anticipated to issue its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect the company to announce earnings of $0.39 per share and revenue of $206.4220 million for the quarter. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS.Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 4:30 PM ET.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs’s revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Stock Performance

Shares of ALAB opened at $186.68 on Friday. The company’s 50-day simple moving average is $196.43 and its 200-day simple moving average is $136.38. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The stock has a market capitalization of $31.03 billion, a PE ratio of 333.36, a P/E/G ratio of 4.66 and a beta of 1.43.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ALAB. Stifel Nicolaus increased their target price on shares of Astera Labs from $174.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Evercore ISI lifted their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, August 6th. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Finally, Barclays reiterated an “equal weight” rating and issued a $155.00 target price on shares of Astera Labs in a report on Monday, October 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $162.06.

Insider Transactions at Astera Labs

In related news, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares of the company’s stock, valued at $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This trade represents a 25.31% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,092,997 shares of company stock valued at $192,231,120 over the last ninety days. Company insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently bought and sold shares of ALAB. Royal Bank of Canada increased its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the last quarter. First Trust Advisors LP grew its holdings in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. grew its holdings in shares of Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after purchasing an additional 1,977 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.